Pacific Biosciences Of California PACB
NASDAQ PACB
$2.17 +0.34 (+18.66%)
As of: Sep 30, 2026 · 10:19 AM EDT

Pacific Biosciences Of California (PACB) Construction in Progress (2016)

Updated

Pacific Biosciences Of California's Construction in Progress was $5.8 million in Q4 2016.

Analysis

Pacific Biosciences Of California (PACB) Construction in Progress (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn -
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn -
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn -
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn -
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn -
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn -
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 911.00 Mn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn -
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn -
10 Pacific Biosciences Of California 531.49 Mn -559.51 Mn 12.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 5.80 Mn
API Access

Pacific Biosciences Of California Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=PACB&period=max&api_key=YOUR_API_KEY